A 1,000 Patient Trial for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies is Now Enrolling
source: pixabay.com

A 1,000 Patient Trial for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies is Now Enrolling

The Platform Notable's automated technology platform was created to help predict which patients would respond better to which therapies. As no patient is the same, this study is paramount. Notable…

Continue Reading A 1,000 Patient Trial for Acute Lymphoblastic Leukemia and Other Hematologic Malignancies is Now Enrolling
As the ACA Faces Another Court Challenge, Patient Groups Urge Quick Action
source: pixabay.com

As the ACA Faces Another Court Challenge, Patient Groups Urge Quick Action

According to a story from newsroom.heart.org, one of the most substantial domestic policy achievements of the Obama administration was the passage of the Affordable Care Act (ACA). Since its passage,…

Continue Reading As the ACA Faces Another Court Challenge, Patient Groups Urge Quick Action
Let’s Talk Spoonies and Compression Socks!
Compression socks come in all different styles and patterns so even though this image is from a stock website, we have no way of knowing these guys AREN'T wearing compression socks.

Let’s Talk Spoonies and Compression Socks!

I've been hearing people buzz about compression socks/stockings for a while, but I've never invested in a pair myself. They're basically what they sound like-- socks or stockings that... compress.…

Continue Reading Let’s Talk Spoonies and Compression Socks!
Searching for the Cause of Lung Disease in Systemic Juvenile Idiopathic Arthritis
source: pixabay.com

Searching for the Cause of Lung Disease in Systemic Juvenile Idiopathic Arthritis

  According to a recent article in MedPage Today’s 2019 year-end review, the number of life-threatening lung diseases in systemic juvenile idiopathic arthritis (sJIA) patients has been increasing. sJIA is…

Continue Reading Searching for the Cause of Lung Disease in Systemic Juvenile Idiopathic Arthritis
Risdiplam Delivers An Improvement to Infants with Spinal Muscular Atrophy Type 1
source: pixabay.com

Risdiplam Delivers An Improvement to Infants with Spinal Muscular Atrophy Type 1

Genentech (Roche Group) announced positive results of its FIREFISH trial in a recent Business Wire news release.  The second part of the study evaluated risdiplam’s efficacy on infants ages one…

Continue Reading Risdiplam Delivers An Improvement to Infants with Spinal Muscular Atrophy Type 1

Blood Thinners Improves Quality of Life With Idiopathic Pulmonary Arterial Hypertension, Worsens Those with Other Variation

A medication that works for some patients with a rare disease may not be effective for others, even with the same disease. For rare diseases, this is important because sample…

Continue Reading Blood Thinners Improves Quality of Life With Idiopathic Pulmonary Arterial Hypertension, Worsens Those with Other Variation
Acromegaly Community to Host Patient-Focused Drug Development Meeting with FDA
source: pixabay.com

Acromegaly Community to Host Patient-Focused Drug Development Meeting with FDA

On April 28th, 2020, Acromegaly Community, a nonprofit organization that is dedicated to supporting acromegaly patients, will be hosting a patient focused drug development meeting (PFDD). These meetings are an…

Continue Reading Acromegaly Community to Host Patient-Focused Drug Development Meeting with FDA
AI Therapeutics’ LAM-002 Shows Positive Results in Treating Follicular Lymphoma and Hope for ALS
source: pixabay.com

AI Therapeutics’ LAM-002 Shows Positive Results in Treating Follicular Lymphoma and Hope for ALS

  AI Therapeutics is a biotechnology company that uses artificial intelligence to match drugs to indications. They do so through the use of their algorithm, Guardian Angel. This algorithm has…

Continue Reading AI Therapeutics’ LAM-002 Shows Positive Results in Treating Follicular Lymphoma and Hope for ALS
Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss
source: pixabay.com

Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss

According to a story from Medical Xpress, a team of researchers from the medical school at the University of Massachusetts has revealed new information about the nature of neurodegenerative symptoms…

Continue Reading Study Suggests that Gene Therapy Could Protect Multiple Sclerosis Patients from Vision Loss
Medical College of Wisconsin Creates ER Alternative for Treating Myeloproliferative Neoplasms and Other Cancers
source: pixabay.com

Medical College of Wisconsin Creates ER Alternative for Treating Myeloproliferative Neoplasms and Other Cancers

Cancer patients often face adverse effects from their treatment. These effects typically need to be addressed by a doctor, whether they're nausea, rashes, or anything else. The issue is that…

Continue Reading Medical College of Wisconsin Creates ER Alternative for Treating Myeloproliferative Neoplasms and Other Cancers